Latest Breaking News On - Us sales biopharmaceutical division - Page 1 : comparemela.com

Published: May 06, 2021 EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) Antares Pharma, Inc.. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior Vice President of Commercial. Mr. Renda succeeds Patrick Shea who resigned to pursue other interests. Mr. Renda has had a successful career in leading commercial sales, marketing, and operations at large and mid-sized pharmaceutical companies. Prior to joining Antares, Mr. Renda was Vice President, U.S. Sales Autoimmune and Rare Disease at Mallinckrodt Pharmaceuticals where he led a 200-person organization responsible for over $1B in annual sales and managed 5 unique therapeutic areas and institutional account teams. From 2012 to 2018, he held various positions of increasing responsibility at Novo Nordisk including Marketing Brand Director, Women’s Health Care and leading the commercial operations and effectiveness function responsible for a 150-person sa

Josephv rendaPatrick sheaWomen health careTeva pharmaceutical industries ltdCompany annual report on formPfizer incIdorsia pharmaceuticalsUpjohn companyRare disease at mallinckrodt pharmaceuticalsUs sales biopharmaceutical divisionFerring pharmaceuticalsPennsylvania state universityPharmacia corporationExchange commissionCorporate communicationsAntares pharma